Identification of kinectin as a novel Behçet's disease autoantigen.

Abstract:

:There has been some evidence that Behçet's disease (BD) has a significant autoimmune component but the molecular identity of putative autoantigens has not been well characterized. In the initial analysis of the autoantibody profile in 39 Chinese BD patients, autoantibodies to cellular proteins were uncovered in 23% as determined by immunoblotting. We have now identified one of the major autoantibody specificities using expression cloning. Serum from a BD patient was used as a probe to immunoscreen a lambdaZAP expression cDNA library. Candidate autoantigen cDNAs were characterized by direct nucleotide sequencing and their expressed products were examined for reactivity to the entire panel of BD sera using immunoprecipitation. Reactivity was also examined with normal control sera and disease control sera from patients with lupus and Sjögren's syndrome. Six independent candidate clones were isolated from the cDNA library screen and were identified as overlapping partial human kinectin cDNAs. The finding that kinectin was an autoantigen was verified in 9 out of 39 (23%) BD patient sera by immunoprecipitation of the in vitro translation products. Sera from controls showed no reactivity. The significance of kinectin as a participant in autoimmune pathogenesis in BD and the potential use of autoantibody to kinectin in serodiagnostics are discussed.

journal_name

Arthritis Res Ther

authors

Lu Y,Ye P,Chen SL,Tan EM,Chan EK

doi

10.1186/ar1798

keywords:

subject

Has Abstract

pub_date

2005-01-01 00:00:00

pages

R1133-9

issue

5

eissn

1478-6354

issn

1478-6362

pii

ar1798

journal_volume

7

pub_type

杂志文章
  • The changing landscape of the clinical value of the PM/Scl autoantibody system.

    abstract::Autoantibodies to the polymyositis/scleroderma (PM/Scl) complex have been associated with systemic sclerosis and PM/Scl overlap syndrome. The report of Hanke and colleagues in a recent issue of Arthritis Research and Therapy is the first to describe the separate evaluation of anti-PM/Scl-75c and PM/Scl-100 autoantibod...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar2646

    authors: Mahler M,Fritzler MJ

    更新日期:2009-01-01 00:00:00

  • Soluble IL-18 receptor complex: a new star in the firmament of rheumatoid arthritis diagnosis?

    abstract::It has long been recognized that laboratory tests are useful in the diagnosis of disease and to monitor treatment outcome. Their performance has become even more demanding with the development of personalized medicine. In patients with rheumatoid arthritis (RA) the standard biochemical tests measure serological marker...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar3308

    authors: van de Loo FA

    更新日期:2011-04-27 00:00:00

  • NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity.

    abstract:BACKGROUND:In previous studies, we demonstrated that the NEMO score, i.e. the cumulative number of microhaemorrhages (MHEs) and microthromboses (MTs), observed in nailfold videocapillaroscopy was a good indicator of the steady state level of disease activity (DA) in patients with systemic sclerosis (SSc) when the Europ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-019-2032-6

    authors: Pignataro F,Maglione W,Minniti A,Sambataro D,Sambataro G,Campanaro F,Valentini G,Vitali C,Del Papa N

    更新日期:2019-11-29 00:00:00

  • Synovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritis.

    abstract:INTRODUCTION:Inflammatory arthritis is associated with increased bone resorption and suppressed bone formation. The Wnt antagonist dickkopf-1 (DKK1) is secreted by synovial fibroblasts in response to inflammation and this protein has been proposed to be a master regulator of bone remodelling in inflammatory arthritis. ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4065

    authors: Hardy R,Juarez M,Naylor A,Tu J,Rabbitt EH,Filer A,Stewart PM,Buckley CD,Raza K,Cooper MS

    更新日期:2012-10-18 00:00:00

  • Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis.

    abstract:BACKGROUND:Biological therapies have improved the clinical course and quality of life of rheumatoid arthritis (RA) patients. Despite the availability and effectiveness of these treatments, some patients experience multiple failures to biologic disease-modifying antirheumatic drugs (bDMARDs), constituting a particular c...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-020-02354-1

    authors: Novella-Navarro M,Plasencia C,Tornero C,Navarro-Compán V,Cabrera-Alarcón JL,Peiteado-López D,Nuño L,Monjo-Henry I,Franco-Gómez K,Villalba A,Balsa A

    更新日期:2020-12-09 00:00:00

  • A Dose-response relationship between severity of disc degeneration and intervertebral disc height in the lumbosacral spine.

    abstract:INTRODUCTION:Varied definitions of disc pathology exist in the literature. Magnetic Resonance Imaging (MRI) classification systems incorporate several qualitative features including disc appearance, the distinction between the nucleus and the annulus, signal intensity and intervertebral disc height. The lack of a conti...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-015-0820-1

    authors: Teichtahl AJ,Urquhart DM,Wang Y,Wluka AE,Heritier S,Cicuttini FM

    更新日期:2015-10-23 00:00:00

  • Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.

    abstract::Lupus nephritis is a major contributor to morbidity and mortality in systemic lupus erythematosus, but little is known about the pathogenic processes that underlie the progressive decay in renal function. A common finding in lupus nephritis is thickening of glomerular basement membranes associated with immune complex ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar2532

    authors: Tveita A,Rekvig OP,Zykova SN

    更新日期:2008-01-01 00:00:00

  • Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplasty.

    abstract:INTRODUCTION:Serious infection, cardiovascular disease, and mortality are increased in rheumatoid arthritis (RA). Whether RA affects the risk for these complications after total joint arthroplasty (TJA) is unknown, we hypothesize that it does. We compared the occurrence of 30-day postoperative complications and mortali...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4385

    authors: Michaud K,Fehringer EV,Garvin K,O'Dell JR,Mikuls TR

    更新日期:2013-01-01 00:00:00

  • Pulmonary arterial hypertension in scleroderma: care gaps in screening.

    abstract::One in six patients with systemic sclerosis will develop pulmonary arterial hypertension (PAH). Screening with echocardiography and possibly pulmonary function testing (to determine the diffusing capacity of carbon monoxide) is recommended to detect PAH at a less severe stage. However, real-world screening programs ha...

    journal_title:Arthritis research & therapy

    pub_type: 社论

    doi:10.1186/s13075-017-1347-4

    authors: Pope JE

    更新日期:2017-06-06 00:00:00

  • Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis.

    abstract:INTRODUCTION:Standard measurements used to assess murine models of rheumatoid arthritis, notably paw thickness and clinical score, do not align well with certain aspects of disease severity as assessed by histopathology. We tested the hypothesis that non-invasive optical tomographic imaging of molecular biomarkers of i...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3038

    authors: Peterson JD,Labranche TP,Vasquez KO,Kossodo S,Melton M,Rader R,Listello JT,Abrams MA,Misko TP

    更新日期:2010-01-01 00:00:00

  • Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection.

    abstract:INTRODUCTION:Intraarticular administration of autologous conditioned serum (ACS) recently demonstrated some clinical effectiveness in treatment of osteoarthritis (OA). The current study aims to evaluate the in vitro effects of ACS on cartilage proteoglycan (PG) metabolism, its composition and the effects on synovial fl...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3050

    authors: Rutgers M,Saris DB,Dhert WJ,Creemers LB

    更新日期:2010-01-01 00:00:00

  • TGF beta-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7.

    abstract::Cartilage damage in osteoarthritis (OA) is considered an imbalance between catabolic and anabolic factors, favoring the catabolic side. We assessed whether adenoviral overexpression of transforming growth factor-beta (TGFbeta) enhanced cartilage repair and whether TGFbeta-induced fibrosis was blocked by local expressi...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar1931

    authors: Blaney Davidson EN,Vitters EL,van den Berg WB,van der Kraan PM

    更新日期:2006-01-01 00:00:00

  • Enhanced interleukin-1β production of PBMCs from patients with gout after stimulation with Toll-like receptor-2 ligands and urate crystals.

    abstract:INTRODUCTION:Monosodium urate monohydrate (MSU) crystals synergize with various toll-like receptor (TLR) ligands to induce cytokine production via activation of the NOD-like receptor (NLR) family, pyrin domain-containing 3 (NLPR3) inflammasome. This has been demonstrated in vitro using human cell lines or monocytes of ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3898

    authors: Mylona EE,Mouktaroudi M,Crisan TO,Makri S,Pistiki A,Georgitsi M,Savva A,Netea MG,van der Meer JW,Giamarellos-Bourboulis EJ,Joosten LA

    更新日期:2012-07-04 00:00:00

  • Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study.

    abstract:BACKGROUND:With advancement in the treatment options of rheumatoid arthritis (RA), optimising the outcomes of difficult-to-treat patients has become increasingly important in clinical practice. In particular, insensitivity to first-line biologic disease-modifying anti-rheumatic drugs (bDMARD) is becoming a significant ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-020-2122-5

    authors: Ochi S,Saito K,Mizoguchi F,Kato S,Tanaka Y

    更新日期:2020-03-04 00:00:00

  • Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?

    abstract:INTRODUCTION:Studies investigating genetic risk factors for susceptibility to rheumatoid arthritis (RA) studied anti-citrullinated peptide antibody (CCP)-positive RA more frequently than anti-CCP-negative RA. One of the reasons for this is the perception that anti-CCP-negative RA may include patients that fulfilled cri...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3505

    authors: De Rooy DP,Willemze A,Mertens B,Huizinga TW,Van der Helm-van Mil AH

    更新日期:2011-01-01 00:00:00

  • Biology of RANK, RANKL, and osteoprotegerin.

    abstract::The discovery of the receptor activator of nuclear factor-kappaB ligand (RANKL)/RANK/osteoprotegerin (OPG) system and its role in the regulation of bone resorption exemplifies how both serendipity and a logic-based approach can identify factors that regulate cell function. Before this discovery in the mid to late 1990...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar2165

    authors: Boyce BF,Xing L

    更新日期:2007-01-01 00:00:00

  • Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4.

    abstract:INTRODUCTION:Osteoarthritis (OA) is a degenerative disease characterized by cartilage breakdown in the synovial joints. The presence of low-grade inflammation in OA joints is receiving increasing attention, with synovitis shown to be present even in the early stages of the disease. How the synovial inflammation arises ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3555

    authors: Sohn DH,Sokolove J,Sharpe O,Erhart JC,Chandra PE,Lahey LJ,Lindstrom TM,Hwang I,Boyer KA,Andriacchi TP,Robinson WH

    更新日期:2012-01-08 00:00:00

  • Perspectives on epigenetic-based immune intervention for rheumatic diseases.

    abstract::Rheumatic disease can loosely be described as any painful condition affecting the loco-motor system, including joints, muscles, connective tissues, and soft tissues around the joints and bones. There is a wide spectrum of rheumatic diseases, many of which involve autoimmunity, including systemic lupus erythematosus an...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar4167

    authors: Gray SG

    更新日期:2013-03-14 00:00:00

  • Cardiovascular risk in pediatric-onset rheumatological diseases.

    abstract::Cardiovascular morbidity and mortality are becoming major health concerns for adults with inflammatory rheumatic diseases. The enhanced atherogenesis in this patient population is promoted by the exposure to traditional risk factors as well as nontraditional cardiovascular insults, such as corticosteroid therapy, chro...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar4212

    authors: Barsalou J,Bradley TJ,Silverman ED

    更新日期:2013-01-01 00:00:00

  • Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis.

    abstract::Rheumatoid arthritis (RA) is a systemic autoimmune disease manifesting in joint destruction. The recognized hallmark of RA pathogenesis is the involvement of immune cells which produce many mediators potentiating an inflammatory environment. RA synovial fibroblasts (RASFs) contribute significantly to disease progressi...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/s13075-015-0846-4

    authors: Chapoval SP

    更新日期:2015-11-06 00:00:00

  • Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis.

    abstract:INTRODUCTION:Mesenchymal stem cells (MSCs) represent promising applications in rheumatoid arthritis (RA). However, the inflammatory niche in the RA synovium could adversely affect MSC function. This study was designed to investigate biologic and immunologic properties of synovium-derived MSCs (SMSCs) in RA, with partic...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4355

    authors: Zhang Z,Ding Y,Li W,Song B,Yang R

    更新日期:2013-10-29 00:00:00

  • Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.

    abstract:INTRODUCTION:Genetic susceptibility to complex diseases has been intensively studied during the last decade, yet only signals with small effect have been found leaving open the possibility that subgroups within complex traits show stronger association signals. In rheumatoid arthritis (RA), autoantibody production serve...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-014-0414-3

    authors: Snir O,Gomez-Cabrero D,Montes A,Perez-Pampin E,Gómez-Reino JJ,Seddighzadeh M,Klich KU,Israelsson L,Ding B,Catrina AI,Holmdahl R,Alfredsson L,Klareskog L,Tegnér J,Gonzalez A,Malmström V,Padyukov L

    更新日期:2014-08-20 00:00:00

  • Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome.

    abstract::Macrophage activation syndrome (MAS) has been reported in association with many rheumatic diseases, most commonly in systemic juvenile rheumatoid arthritis (sJRA). Clinically, MAS is similar to hemophagocytic lymphohistiocytosis (HLH), a genetic disorder with absent or depressed natural killer (NK) function. We have p...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar1453

    authors: Villanueva J,Lee S,Giannini EH,Graham TB,Passo MH,Filipovich A,Grom AA

    更新日期:2005-01-01 00:00:00

  • Randomized controlled studies on the efficacy of antiarthritic agents in inhibiting cartilage degeneration and pain associated with progression of osteoarthritis in the rat.

    abstract:BACKGROUND:As an initial step in the development of a local therapeutic to treat osteoarthritis (OA), a number of agents were tested for their ability to block activation of inflammation through nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB), subchondral bone changes through receptor activator of nu...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-016-0921-5

    authors: TenBroek EM,Yunker L,Nies MF,Bendele AM

    更新日期:2016-01-21 00:00:00

  • Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors.

    abstract:INTRODUCTION:The interaction between the immune and skeletal systems is evidenced by the bone loss observed in autoimmune diseases such as rheumatoid arthritis. In this paper we describe a new mechanism by which the immune cytokine IL-17A directly affects osteoclastogenesis. METHODS:Human CD14+ cells were isolated fro...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2936

    authors: Adamopoulos IE,Chao CC,Geissler R,Laface D,Blumenschein W,Iwakura Y,McClanahan T,Bowman EP

    更新日期:2010-01-01 00:00:00

  • New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis.

    abstract::Recent genome-wide association studies have implicated the tumor necrosis factor receptor-associated factor 3-interacting protein 2 (TRAF3IP2) gene and its product, nuclear factor-kappa-B activator 1 (Act1), in the development of psoriatic arthritis (PsA). The high level of sequence homology of the TRAF3IP2 (Act1) gen...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar4071

    authors: Doyle MS,Collins ES,FitzGerald OM,Pennington SR

    更新日期:2012-10-31 00:00:00

  • Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study.

    abstract:BACKGROUND:Pain is one of the most important domains affecting health-related quality of life (HRQoL) in patients with psoriatic arthritis (PsA). Secukinumab has demonstrated rapid and sustained improvements in signs and symptoms, including HRQoL, among patients with active PsA. This analysis evaluates the effect of se...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s13075-018-1610-3

    authors: McInnes IB,Mease PJ,Schett G,Kirkham B,Strand V,Williams N,Fox T,Pricop L,Jugl SM,Gandhi KK,FUTURE 2 Study Group.

    更新日期:2018-06-07 00:00:00

  • Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus.

    abstract:INTRODUCTION:Systemic lupus erythematosus is a chronic autoimmune disease characterized by an abundance of autoantibodies against nuclear antigens. Bruton's tyrosine kinase (Btk) is a proximal transducer of the BCR signal that allows for B-cell activation and differentiation. Recently, selective inhibition of Btk by PC...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4086

    authors: Hutcheson J,Vanarsa K,Bashmakov A,Grewal S,Sajitharan D,Chang BY,Buggy JJ,Zhou XJ,Du Y,Satterthwaite AB,Mohan C

    更新日期:2012-11-08 00:00:00

  • Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?

    abstract::Pleiotropic effects are now described for the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (or statins) that might have utility in the context of chronic inflammatory autoimmune disease. Here we discuss the pharmacology and established uses of statins and in this context describe potential anti-inflammat...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar1496

    authors: McCarey DW,Sattar N,McInnes IB

    更新日期:2005-01-01 00:00:00

  • Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus.

    abstract:INTRODUCTION:Despite growing evidence that large intergenic noncoding RNAs (lincRNAs) can regulate gene expression and widely take part in normal physiological and disease conditions, our knowledge of systemic lupus erythematosus (SLE)-related lincRNAs remains limited. The aim of this study was to detect the levels of ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-015-0632-3

    authors: Wu Y,Zhang F,Ma J,Zhang X,Wu L,Qu B,Xia S,Chen S,Tang Y,Shen N

    更新日期:2015-05-21 00:00:00